Fees are a weakness here. The strategy's lofty fees are a high hurdle to clear, as it is priced within the second-highest quintile among peers.
Empower Core Strategies Intl Eq Inv MXEVX
- NAV / 1-Day Return 10.42 / +0.97 %
- Total Assets 765.2 Mil
-
Adj. Expense Ratio
- Expense Ratio 1.000%
- Distribution Fee Level Above Average
- Share Class Type No Load
- Category Foreign Large Blend
- Investment Style Large Blend
- Min. Initial Investment —
- Status Open
- TTM Yield 1.86%
- Turnover 16%
USD | NAV as of May 04, 2024 | 1-Day Return as of May 04, 2024, 12:13 AM GMT+0
Morningstar’s Analysis MXEVX
Will MXEVX outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 10.5
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
---|---|---|---|
Novartis AG Registered Shares | 1.52 | 8.8 Mil | Healthcare |
ASML Holding NV | 1.35 | 7.8 Mil | Technology |
Shell PLC | 1.24 | 7.2 Mil | Energy |
Novo Nordisk A/S Class B | 1.04 | 6.0 Mil | Healthcare |
Roche Holding AG | 0.99 | 5.7 Mil | Healthcare |
Nestle SA | 0.95 | 5.5 Mil | Consumer Defensive |
TotalEnergies SE | 0.94 | 5.5 Mil | Energy |
HSBC Holdings PLC | 0.84 | 4.8 Mil | Financial Services |
Sanofi SA | 0.81 | 4.7 Mil | Healthcare |
Alcon Inc | 0.80 | 4.6 Mil | Healthcare |